Page last updated: 2024-10-23

biperiden and Disease Models, Animal

biperiden has been researched along with Disease Models, Animal in 18 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"In order to elucidate the neural mechanisms of delirium, we administered the anticholinergic drug, biperiden (40 mg/kg i."7.73Biperiden-induced delirium model in rats: a behavioral and electroencephalographic study. ( Chiba, S; Ishimaru, Y; Ishimoto, T; Tabata, K; Takasaki, H; Tamura, Y, 2006)
"In order to elucidate the neural mechanisms of delirium, we administered the anticholinergic drug, biperiden (40 mg/kg i."3.73Biperiden-induced delirium model in rats: a behavioral and electroencephalographic study. ( Chiba, S; Ishimaru, Y; Ishimoto, T; Tabata, K; Takasaki, H; Tamura, Y, 2006)
"The ability of the nerve agents tabun, sarin, soman, GF, VR, and VX to produce brain seizures and the effectiveness of the anticholinergics biperiden HCl or atropine SO4 as an anticonvulsant treatment were studied in a guinea-pig model."3.70Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication. ( McDonough, JH; Shih, TM, 2000)
"Donepezil was able to fully reverse the effects of biperiden on N50 sensory gating, but had residual effects when combined with scopolamine; i."1.39Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats. ( Blokland, A; Klinkenberg, I; Sambeth, A, 2013)
"When biperiden was combined with SKF-82958, contraversive circling also was enhanced and ipsiversive circling decreased."1.35Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions. ( Domino, EF; Ni, L, 2008)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19902 (11.11)18.7374
1990's2 (11.11)18.2507
2000's5 (27.78)29.6817
2010's8 (44.44)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Solinski, HJ1
Dranchak, P1
Oliphant, E1
Gu, X1
Earnest, TW1
Braisted, J1
Inglese, J1
Hoon, MA1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Bittencourt, S1
Ferrazoli, E1
Valente, MF1
Romariz, S1
Janisset, NRLL1
Macedo, CE1
Antonio, BB1
Barros, V1
Mundim, M1
Porcionatto, M1
Aarão, MC1
Miranda, MF1
Rodrigues, AM1
de Almeida, AG1
Longo, BM1
Mello, LE1
Popelíková, A1
Bahník, Š1
Lobellová, V1
Svoboda, J1
Stuchlík, A1
Hailwood, JM1
Heath, CJ1
Phillips, BU1
Robbins, TW1
Saksida, LM1
Bussey, TJ1
Szczodry, O1
van der Staay, FJ1
Arndt, SS1
Domino, EF2
Ni, L1
Klinkenberg, I2
Blokland, A2
Asth, L1
Lobão-Soares, B1
André, E1
Soares, Vde P1
Gavioli, EC1
Sambeth, A1
Hamann, M1
Meisler, MH1
Richter, A1
Tamura, Y1
Chiba, S1
Takasaki, H1
Tabata, K1
Ishimaru, Y1
Ishimoto, T1
Kovacic, B1
Kehr, W1
Shih, TM1
McDonough, JH1
Yoshida, K1
Takahashi, H1
Sato, K1
Higuchi, H1
Shimizu, T1
Carlsson, M1
Svensson, A1
Carlsson, A1
Tan, U1
Gepdíremen, A1
Banoglu, N1
Kutlu, N1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Biperiden for Prevention of Epilepsy in Patients With Traumatic Brain Injury[NCT04945213]Phase 3312 participants (Anticipated)Interventional2023-01-10Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

18 other studies available for biperiden and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Modification of the natural progression of epileptogenesis by means of biperiden in the pilocarpine model of epilepsy.
    Epilepsy research, 2017, Volume: 138

    Topics: Action Potentials; Animals; Autonomic Nervous System; Biperiden; Chronic Disease; Cytokines; Disease

2017
Mnemonic and behavioral effects of biperiden, an M1-selective antagonist, in the rat.
    Psychopharmacology, 2018, Volume: 235, Issue:7

    Topics: Alzheimer Disease; Animals; Behavior, Animal; Biperiden; Cognitive Dysfunction; Disease Models, Anim

2018
Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019, Volume: 44, Issue:6

    Topics: Animals; Antipsychotic Agents; Apathy; Behavior, Animal; Biperiden; Cognitive Dysfunction; Disease M

2019
Modelling Alzheimer-like cognitive deficits in rats using biperiden as putative cognition impairer.
    Behavioural brain research, 2014, Nov-01, Volume: 274

    Topics: Animals; Biperiden; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; M

2014
Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.
    European journal of pharmacology, 2008, Dec-03, Volume: 599, Issue:1-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Benza

2008
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
    Psychopharmacology, 2011, Volume: 215, Issue:3

    Topics: Animals; Behavior, Animal; Biperiden; Cognition Disorders; Disease Models, Animal; Dose-Response Rel

2011
The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice.
    Brain research bulletin, 2012, Apr-10, Volume: 87, Issue:6

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Biperiden; Diazepam; Disease Models, An

2012
Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:8

    Topics: Alzheimer Disease; Animals; Behavior, Animal; Biperiden; Cholinergic Neurons; Cholinesterase Inhibit

2013
Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia.
    Experimental neurology, 2003, Volume: 184, Issue:2

    Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Brain; Diazepam; Disease Models, Animal

2003
Biperiden-induced delirium model in rats: a behavioral and electroencephalographic study.
    Brain research, 2006, Oct-18, Volume: 1115, Issue:1

    Topics: Acetylcholine; Action Potentials; Animals; Behavior, Animal; Biperiden; Brain; Consciousness; Deliri

2006
Monkey models of tardive dyskinesia.
    Modern problems of pharmacopsychiatry, 1983, Volume: 21

    Topics: Animals; Benztropine; Biperiden; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fl

1983
[Drug therapy of Parkinson disease and parkinson disease-like symptoms].
    Arzneimittel-Forschung, 1981, Volume: Suppl 27

    Topics: Adenylyl Cyclases; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biperiden; Brain; Catechol O-Methy

1981
Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication.
    Archives of toxicology, 2000, Volume: 74, Issue:3

    Topics: Animals; Anticonvulsants; Atropine; Biperiden; Cholinesterase Inhibitors; Cholinesterase Reactivator

2000
Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:3

    Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Disease Models, Animal; Guanidines; Hal

2000
Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 1991, Volume: 343, Issue:6

    Topics: Adrenergic alpha-Agonists; Animals; Atropine; Biperiden; Clonidine; Disease Models, Animal; Dizocilp

1991
Intermittent tremor-bursts induced by chlorpromazine and pentobarbitone in guinea pigs: a new tremor model.
    The International journal of neuroscience, 1991, Volume: 61, Issue:3-4

    Topics: Acoustic Stimulation; Animals; Biperiden; Chlorpromazine; Disease Models, Animal; Guinea Pigs; Muscl

1991